In den Warenkorb
Bestellen Sie auch über:
+49 (0)241 95 163 153
+49 (0)241 95 163 155

Epidermal Growth Factor Receptor (EGFR) Antikörper

Antigen

Epidermal Growth Factor Receptor (EGFR)

Synonyme
ERBB, HER1, mENA, ERBB1, PIG61, Wa5, wa2, Erbb, Errp, wa-2, AI552599, 9030024J15Rik, ErbB-1, C-erb, D-EGFR, D-Egf, DEGFR, DER, DER flb, DER/EGFR, DER/faint little ball, DER/top, DER/torpedo, DmHD-33,  ... mehr anzeigen
Klonalität Polyklonal
Wirt
Alternativen

Kaninchen

Reaktivität
Alternativen

Rind (Kuh), Human, Maus, Ratte (Rattus), Schaf

Applikation
Alternativen Immunhistochemie (IHC), ELISA, Western Blot (WB), Immunpräzipitation (IP)
Produktnummer ABIN98862
Menge 250ul  (85 mg/ml (by Refractometry))  (Varianten)
Preis 315,11 €   Zzgl. Versandkosten €20,00 und MWSt
Lieferung nach
Verfügbarkeit Lieferung in 5 Werktagen

Produktbeschreibung

Gen-ID NP_005219
Swiss-Prot P00533
Immunogen This whole rabbit serum was prepared by repeated immunizations with a peptide synthesized using conventional technology. The sequence of the epitope maps to a region near the carboxy terminus which is identical in human, mouse and rat EGFR.
Format Liquid (sterile filtered)
Beschreibung EGFR is a transmembrane glycoprotein that is a member of a family of protein tyrosine kinases crucial to maintaining a normal balance in cell growth and development. Growth factor receptors are involved not only in promoting the proliferation of normal cells but also in the aberrant growth of many types of human tumors. For example, the epidermal growth factor receptor (EGFR) is mutated and/or over-expressed in many common solid human squamous cell carcinomas including breast, brain, bladder, lung, gastric, head & neck, esophagus, cervix, vulva, ovary, and endometrium. Over-expression of the EGFR gene occurs in carcinomas with and without gene amplification. EGFR and ErbB-2 are particularly important in breast cancer because increased production or activation has been associated with poor prognosis. EGFR belongs to a family of growth factor receptors, which also includes ErbB-2/HER-2/neu, ErbB-3/HER-3/neu and ErbB-4/HER-4/neu. EGFR can heterodimerize with each of the members of this family.
Spezifität This antiserum is directed against human epidermal growth factor receptor (EGFR) and is useful in determining its presence in western blotting and immunoprecipitation experiments. This antibody can detect EGFR from human, mouse and rat sources. Reactivity of this antibody with EGFR from other species is unknown.
Synonyme ERBB, HER1, mENA, ERBB1, PIG61, Wa5, wa2, Erbb, Errp, wa-2, AI552599, 9030024J15Rik, ErbB-1, C-erb, D-EGFR, D-Egf, DEGFR, DER, DER flb, DER/EGFR, DER/faint little ball, DER/top, DER/torpedo, DmHD-33, EFG-R, EGF-R, EGFR, EK2-6, Egf, El, Elp, Elp-1, Elp-B1, Elp-B1RB1, HD-33, Torpedo/DER, Torpedo/Egfr, c-erbB, d-egf-r, dEGFR1, flb, l(2)05351, l(2)09261, l(2)57DEFa, l(2)57EFa, l(2)57Ea, pnt, top, top/DER, top/flb, DmelCG10079, CG10079, egfr, EGFR12, EGFR15, egfr1, Erbb2

Anwendungen

Applikationshinweise Recommended Dilutions: ELISA 1:10,000 - 1:50,000 WESTERN BLOT 1:1,000 - 1:10,000 IMMUNOPRECIPITATION 10 u l OTHER APPLICATIONS User Optimized. Note: Anti-EGFR antibody is specifically designed for ELISA, immunoblotting and immunoprecipitation. Reactivity in other assays is likely, but has not been determined. Recognition of EGFR is independent of the phosphorylation status at tyrosine 1173. No reaction is observed against ErbB-2, ErbB-3 or ErbB-4. A431 cells, keratinocytes in normal epidermis, or placenta are typically used as positive control sources. The antigen is typically localized in the cell membrane. For western blotting, good results are also achieved on PVDF membranes blocked with 5% lowfat milk diluted in TTBS for 1 hour at room temperature. Also, dilute the primary antibody and secondary in 5% lowfat milk in TTBS. Anti-EGFR can be diluted up to 1:10,000 for immunoblot depending on the cell line and the amount of EGFR in a particular lysate. For immunoprecipitation, use approximately 10 u l of the antibody. The immunoprecipitation mix should contain the antibody, 25 u l of Protein A-agarose beads and 1.0 ml of lysate (lysate contains approximately 1.0 mg of total protein). This mixture should be rotated overnight at 4
Konzentration 85 mg/ml (by Refractometry)
Buffer Stabilizer: None. Preservative: 0.01% (w/v) Sodium Azide. Buffer: None.
Lagerung Store vial at -20° C prior to opening. For extended storage, aliquot contents and freeze at -20° C or below. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use. Expiration date is one (1) year from date of opening. General
Forschungsgebiet Wachstumsfaktoren, Hormone, Krebs
Beschränkungen Nur für Forschungszwecke einsetzbar

Alternativen

Alternativen zu Antigen "Epidermal Growth Factor Receptor (EGFR)", Typ "Antikörper" finden
Wirte Kaninchen (472), Maus (193), Ratte (17), Schaf (13), Ziege (2), Huhn (1)
Reaktivitäten Human (670), Maus (284), Ratte (Rattus) (258), Hund (36), Schwein (19), Kaninchen (18), Huhn (9), Rind (Kuh) (5), Pferd (4), Schaf (1)
Applikationen Western Blot (WB) (484), Immunpräzipitation (IP) (161), Immunhistochemie (Paraffinschnitte) (IHC (p)) (159), Enzyme Immunoassay (EIA) (125), Immunfluoreszenz (IF) (118), Durchflusszytometrie (FACS) (107), Immunhistochemie (IHC) (104), ELISA (95), Immunhistochemie (Gefrierschnitte) (IHC (fro)) (69), Dot Blot (Dot) (28), Blocking Antibody (Inhibition) (16), Immunzytochemie (ICC) (12), Immunhistochemie (formalinfixierte Schnitte) (IHC (f)) (4), Funktionale Studien (Func) (3), ELISA (Detektionsantikörper) (2), Immunelektronenmikroskopie (EM) (2), Immunoelectron Microscopy (IEM) (2), Neutralisierung (Neut) (2), Blockierende Antikörper (Inhibition) (1), Radioimmunoassay (RIA) (1)
Konjugate Biotin (35), FITC (8), PE (5), Alexa Fluor 488 (3), Alexa Flour 488 (2), Alexa Fluor 350 (2), Alexa Fluor 555 (2), Alexa Fluor 647 (2), Cy3 (2), Cy5 (2), Cy5.5 (2), Cy7 (2), Gold (2), HRP (2), PE,Cy3 (2), PE,Cy5 (2), PE,Cy5.5 (2), PE,Cy7 (2), RBITC (2)
Epitope pTyr1197 (20), C-Term (17), pTyr869 (15), pTyr1092 (14), pThr678 (13), pTyr1172 (13), pTyr1110 (12), pSer1070 (11), pThr693 (11), AA 985-996 (5), N-Term (5), pTyr1016 (5), pTyr1068 (4), pTyr1069 (4), pTyr1173 (4), pSer695 (3), AA 1-203 (2), AA 1140-1160 (2), AA 960-980 (2), Extracell. non Ligand binding Site (2), S695 (2), Y1125 (2), Y869 (2), Y998 (2), pSer1026 (2), pSer1071 (2), pSer1166 (2), pSer1190 (2), pSer768 (2), pTyr1125 (2), pTyr845 (2), pTyr992 (2), pTyr998 (2), AA 1189-1199 (1), AA 25-140 (1), Ab-1016 (1), Ab-1026 (1), Ab-1069 (1), Ab-1071 (1), Amino Acids 1165-1186 (1), External Domain (1), Extracellular non-ligand binding site (1), S1026 (1), S1070 (1), S1071 (1), S1166 (1), S1190 (1), S991 (1), T678 (1), TYR1173 (1), Y1016 (1), Y1069 (1), Y1092 (1), Y1110 (1), Y1172 (1), Y978 (1), extracellular ligand binding site (1), internal (1), pS1070 (1), pS768 (1), pSer1070/1071 (1), pSer1142 (1), pSer967 (1), pTyr1086 (1), pTyr1101 (1), pTyr1148 (1), pTyr1173, pTyr1248 (1), pY1016 (1), pY1092 (1), pY1172 (1), prylated At Threonine 654 (1), prylated At Tyrosine 1045 (1), prylated At Tyrosine 1173 (1), prylated At Tyrosine 845 (1), prylated at Serine 1047 (1)

Varianten

Varianten